Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05037292 · ClinicalTrials.gov registry record · NA

PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)

A NA study of Frailty, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
35,015
Enrollment target
3
Study locations

NCT05037292: Active NA study of Frailty, sponsored by VA Office of Research and Development.

NCT05037292 is a NA study of Frailty that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 35,015 participants, above the 777-participant average among 48 other Frailty trials with a reported enrollment target (4406% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05037292, a NA study of Frailty, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
35,015 participants
Enrollment target
3
Study locations

Study Summary

The PAUSE Trial is a pragmatic, randomized clinical trial for Veterans scheduled for elective surgery at 3 large VA facilities (Palo Alto, Houston, and Nashville). The PAUSE Trial focuses on cooperation between providers of various disciplines in order to provide better care. Veterans identified as frail upon standardized will be referred to a multidisciplinary "PAUSE Board" comprised of members from surgery, anesthesia, geriatrics, palliative care, case management, rehabilitation, and nutrition. Diverse specialists will come together in a team environment to discuss care options, scientific evidence, and patient goals and expectations, creating individual patient recommendations. The investigators hypothesize that the PAUSE Board model will improve quality and outcomes by promoting guidelines and evidence-based care recommendations as well as constructive team-based discussions to align care with patient goals and expectations.

Conditions Studied

Interventions

  • OTHER PAUSE Intervention

Study Locations (3)

California

  • VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto

Tennessee

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN - Nashville

Texas

  • Michael E. DeBakey VA Medical Center, Houston, TX - Houston

Trial Details

FieldValue
Enrollment Target 35,015 participants
Start Date 2021-10-26
Est. Completion 2026-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05037292

The ClinicalTrials.gov registry entry for NCT05037292 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 35,015 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 777-participant average among 48 other Frailty trials with a reported enrollment target (4406% higher). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Frailty appearing as the primary indexed condition, and to 1 intervention - of which PAUSE Intervention is the first listed.

NCT05037292 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Tennessee, Texas.

Frequently Asked Questions

What is clinical trial NCT05037292 about?

NCT05037292 is a clinical study titled "PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)". The PAUSE Trial is a pragmatic, randomized clinical trial for Veterans scheduled for elective surgery at 3 large VA facilities (Palo Alto, Houston, and Nashville). The PAUSE Trial focuses on cooperation between providers of various disciplines in order to provide better care. Veterans identified as ...

What is the current status of trial NCT05037292?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 35,015 participants. The study started on 2021-10-26. Estimated completion is 2026-09-30.

What conditions does trial NCT05037292 study?

This clinical trial studies the following conditions: Frailty.

What interventions are being tested in trial NCT05037292?

The interventions under investigation include: PAUSE Intervention (OTHER).

Who is sponsoring clinical trial NCT05037292?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05037292 being conducted?

This trial has 3 study locations across California, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Frailty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.